Emerging Infectious Diseases (Oct 2002)

Call-Tracking Data and the Public Health Response to Bioterrorism-Related Anthrax

  • Joshua A. Mott,
  • Tracee A. Treadwell,
  • Thomas W. Hennessy,
  • Paula A. Rosenberg,
  • Mitchell I. Wolfe,
  • Clive M. Brown,
  • Jay C. Butler

DOI
https://doi.org/10.3201/eid0810.020355
Journal volume & issue
Vol. 8, no. 10
pp. 1088 – 1092

Abstract

Read online

After public notification of confirmed cases of bioterrorism-related anthrax, the Centers for Disease Control and Prevention’s Emergency Operations Center responded to 11,063 bioterrorism-related telephone calls from October 8 to November 11, 2001. Most calls were inquiries from the public about anthrax vaccines (58.4%), requests for general information on bioterrorism prevention (14.8%), and use of personal protective equipment (12.0%); 882 telephone calls (8.0%) were referred to the state liaison team for follow-up investigation. Of these, 226 (25.6%) included reports of either illness clinically confirmed to be compatible with anthrax or direct exposure to an environment known to be contaminated with Bacillus anthracis. The remaining 656 (74.4%) included no confirmed illness but reported exposures to “suspicious” packages or substances or the receipt of mail through a contaminated facility. Emergency response staff must handle high call volumes following suspected or actual bioterrorist attacks. Standardized health communication protocols that address contact with unknown substances, handling of suspicious mail, and clinical evaluation of suspected cases would allow more efficient follow-up investigations of clinically compatible cases in high-risk groups.

Keywords